Difference between revisions of "Profiles"
Jump to navigation
Jump to search
Line 35: | Line 35: | ||
*[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| MR Elastography 2017-08-15]] (''Closed on September 15, 2017'') | *[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| MR Elastography 2017-08-15]] (''Closed on September 15, 2017'') | ||
*[[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| MR DWI 2017-04-27]] (''Closed on August 25, 2017'') | *[[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| MR DWI 2017-04-27]] (''Closed on August 25, 2017'') | ||
+ | |||
==Format for Citing Profiles== | ==Format for Citing Profiles== | ||
Cite QIBA Profile documents as: | Cite QIBA Profile documents as: | ||
− | : Specific QIBA Biomarker Committee. | + | : ''Specific QIBA Biomarker Committee. Specific Profile Title'', Quantitative Imaging Biomarkers Alliance. ''Version. Profile Stage''. QIBA, ''Date''. Available from: ''URL'' |
Example: | Example: |
Revision as of 20:02, 18 May 2018
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
Submit comments using the online form: http://tinyurl.com/QIBA-Public-Comment-Form
(Note: each form accommodates 10 comments; submit additional forms as necessary)
- There are currently no Profiles open for Public Comment
Public Comment closed for the following Profiles (comment resolution is underway on the corresponding committee page):
- fMRI 2017-06-19 (Closed on December 31, 2017)
- PET Amyloid: 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02 (Closed on September 15, 2017)
- MR Elastography 2017-08-15 (Closed on September 15, 2017)
- MR DWI 2017-04-27 (Closed on August 25, 2017)
Format for Citing Profiles
Cite QIBA Profile documents as:
- Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. QIBA, Date. Available from: URL
Example:
- QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)